No Data
Barclays Keeps Their Hold Rating on GlaxoSmithKline (GSK)
Top FDA Vaccine Official Resigns Citing RFK Jr.'s 'Misinformation and Lies'
Market Chatter: GSK Wants Pharmaceutical Firms to Have More Access to UK Health Records
J.P. Morgan Sticks to Their Sell Rating for GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK.US) hopes the United Kingdom government will open the NHS database to promote drug development.
GlaxoSmithKline (GSK.US) is urging the United Kingdom government to allow pharmaceutical companies greater access to its public health databases in order to accelerate drug development and prevent the country from declining in the Global life sciences rankings.
Jim Cramer Says 'Buy and Put Away' GSK (GSK) for Its 4% Yield
